Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01827527 · ClinicalTrials.gov registry record
Magnetic Resonance & Optical Spectroscopy Validation
A clinical trial of Validation Studies and Magnetic Resonance Spectroscopy, sponsored by AdventHealth Translational Research Institute.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT01827527 is a study of Validation Studies and Magnetic Resonance Spectroscopy that is actively recruiting participants, run by AdventHealth Translational Research Institute. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01827527, a study of Validation Studies and Magnetic Resonance Spectroscopy, is actively recruiting participants, sponsored by AdventHealth Translational Research Institute.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and refine techniques for using magnetic resonance and optical spectroscopy to investigate how your body uses energy.
Conditions Studied
Study Locations (1)
Florida
- Translational Research Institute for Metabolism and Diabetes - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2013-03 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01827527
The ClinicalTrials.gov registry entry for NCT01827527 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth Translational Research Institute, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Validation Studies appearing as the primary indexed condition, and to 0 interventions.
NCT01827527 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT01827527 about?
NCT01827527 is a clinical study titled "Magnetic Resonance & Optical Spectroscopy Validation". The purpose of this study is to develop and refine techniques for using magnetic resonance and optical spectroscopy to investigate how your body uses energy.
What is the current status of trial NCT01827527?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2013-03. Estimated completion is 2025-12.
What conditions does trial NCT01827527 study?
This clinical trial studies the following conditions: Validation Studies, Magnetic Resonance Spectroscopy.
Who is sponsoring clinical trial NCT01827527?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01827527 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Validation Studies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.